{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T09:59:50Z","timestamp":1771581590664,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.ygyno.2014.12.006","type":"journal-article","created":{"date-parts":[[2014,12,10]],"date-time":"2014-12-10T01:33:50Z","timestamp":1418175230000},"page":"198-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion"],"prefix":"10.1016","volume":"136","author":[{"given":"Koji","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosei","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryusuke","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sosuke","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuhei","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd B.","family":"Sheridan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriomi","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuo","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Fotopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynda D.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil K.","family":"Sood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2014.12.006_bb0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0010","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrc3144","article-title":"Rethinking ovarian cancer: recommendations for improving outcomes","volume":"11","author":"Vaughan","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ygyno.2014.02.016","article-title":"Global distribution pattern of histological subtypes of epithelial ovarian cancer: a database analysis and systematic review","volume":"133","author":"Sung","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0020","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ygyno.2011.01.005","article-title":"Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010","volume":"121","author":"Anglesio","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0025","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ygyno.2012.04.021","article-title":"Clear cell carcinoma of the ovary: a review of the literature","volume":"126","author":"del Carmen","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0030","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2013.31.15_suppl.5534","article-title":"An evaluation of survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: a Gynecologic Oncology Group experience","volume":"31","author":"Farley","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0035","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/cam4.31","article-title":"Significance of lymphovascular space invasion in epithelial ovarian cancer","volume":"1","author":"Matsuo","year":"2012","journal-title":"Cancer Med"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0040","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ygyno.2014.03.563","article-title":"Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian carcinoma","volume":"133","author":"Matsuo","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0045","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/AOG.0000000000000240","article-title":"Effect of lymphovascular space invasion on survival of stage I epithelial ovarian cancer","volume":"123","author":"Matsuo","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0050","first-page":"175","article-title":"Grading of ovarian cancer: a histotype-specific approach","volume":"27","author":"Malpica","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0060","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2014.32.15_suppl.5507","article-title":"Randomized phase III trial of paclitaxel\/carboplatin (PC) versus cisplatin\/irinotecan (CPT-P) as first-line chemotherapy in patients with clear cell carcinoma (CCC) of the ovary: a Japanese Gynecologic Oncology Group (JGOG)\/GCIG study","volume":"32","author":"Okamoto","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0065","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1006\/gyno.1998.4943","article-title":"Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix","volume":"68","author":"Roman","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0070","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1002\/1097-0142(20000601)88:11<2578::AID-CNCR21>3.0.CO;2-Y","article-title":"A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma","volume":"88","author":"Sakuragi","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ygyno.2011.09.017","article-title":"Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer","volume":"124","author":"Guntupalli","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0080","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/gyno.1995.1148","article-title":"The prognostic significance of lymphovascular space invasion in endometrial cancer when conventional hemotoxylin and eosin staining is compared to immunohistochemical staining","volume":"57","author":"Tsuruchi","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0085","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ygyno.2005.12.027","article-title":"Clinical and pathological prognostic factors in squamous cell carcinoma of the vulva","volume":"102","author":"Raspagliesi","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3892\/etm.2011.376","article-title":"Modulation of estrogenic action in clear cell carcinoma of the ovary (Review)","volume":"3","author":"Tanase","year":"2012","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0095","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1464-410X.2007.07015.x","article-title":"Microvascular tumour invasion in renal cell carcinoma: the most important prognostic factor","volume":"100","author":"Dall'Oglio","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0100","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1464-410X.2004.04786.x","article-title":"Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma","volume":"93","author":"Yildiz","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0105","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/bjc.1997.537","article-title":"Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels","volume":"76","author":"Yamamoto","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0110","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1158\/1535-7163.MCT-10-0169","article-title":"Vascular endothelial growth factor is a promising therapeutic target for the treatment of clear cell carcinoma of the ovary","volume":"9","author":"Mabuchi","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1756-9966-31-53","article-title":"Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?","volume":"31","author":"Takano","year":"2012","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0120","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s10147-007-0670-1","article-title":"Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis","volume":"12","author":"Takano","year":"2007","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0125","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/IGC.0b013e3181cafb47","article-title":"Randomized phase II trial of paclitaxel plus carboplatin therapy versus irinotecan plus cisplatin therapy as first-line chemotherapy for clear cell adenocarcinoma of the ovary: a JGOG study","volume":"20","author":"Takakura","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0130","doi-asserted-by":"crossref","first-page":"238061","DOI":"10.1155\/2012\/238061","article-title":"Fertility-sparing surgery in early epithelial ovarian cancer: a viable option?","volume":"2012","author":"Fotopoulou","year":"2012","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0135","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ygyno.2006.06.013","article-title":"Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study","volume":"102","author":"Bell","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2014.12.006_bb0140","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.6004\/jnccn.2013.0142","article-title":"National comprehensive cancer networks. Ovarian cancer, version 2.2013","volume":"11","author":"Morgan","year":"2013","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814015613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814015613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T18:53:21Z","timestamp":1598554401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825814015613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0090825814015613"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.12.006","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}